SANOFINSESanofi India Limited· PharmaceuticalsMediumNeutral
Announced Wed, 25 Mar · 12:49 IST

Sanofi India Limited has informed the Exchange about convening of the Seventieth Annual General Meeting of the Company

Board & Shareholder Meetings View source PDF

SANOFI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.7%1-day move
₹3248.00
prior close
₹3325.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.1-0.0-0.4-2.7-1.3-0.1+0.4+2.6+5.3+10.3+5.5-2.1+2.9
Up moveDown movePending
AI summary

Sanofi India's board, meeting on 25th March 2026, approved convening its 70th Annual General Meeting on 29th April 2026 at 3:30 p.m. via video conferencing. The board confirmed the previously recommended Final Dividend of Rs. 48 per equity share (face value Rs. 10) for the financial year ended 31st December 2025, pending shareholder approval at the AGM. The record date for dividend eligibility is 22nd April 2026, with share transfer books closed from 23rd to 29th April 2026. Additionally, the board approved the appointment of Mr. Siraj Azmat Chaudhry (DIN: 00161853) as an Additional and Independent Director for a 5-year term starting 1st April 2026, subject to shareholder approval. Mr. Chaudhry brings over 35 years of experience, including a decade as Chairman of Cargill India, and currently serves on boards of Jubilant Ingrevia, Carrier Air Conditioning, Bikaji Foods, and Triveni Engineering.

Likely market impact

Shareholders can expect a Rs. 48 per share dividend if approved at the AGM on 29th April 2026, with eligibility determined by holdings as of 22nd April 2026. The appointment of a seasoned independent director with deep FMCG and agriculture expertise may strengthen corporate governance. This is a routine procedural announcement with no immediate material impact on stock price.